Assessment of Long Term, Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
Status: Recruiting
Location: See all (43) locations...
Study Type: Observational
SUMMARY
A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device) or the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements
• Patient has been or is intended to be treated with an eligible registry device
• Patient is age ≥ 18 years at time of informed consent signature.
Locations
United States
Arkansas
Central Arkansas Veteran's Healthcare System
RECRUITING
Little Rock
California
University of Southern California
RECRUITING
Los Angeles
Stanford University School of Medicine
RECRUITING
Palo Alto
Florida
Mount Sinai Vascular Institute
RECRUITING
Miami Beach
University of South Florida
RECRUITING
Tampa
Georgia
Augusta University Medical Center
RECRUITING
Augusta
Atlanta VA Medical Center
RECRUITING
Decatur
Indiana
St. Vincent Medical Group, Inc.
RECRUITING
Indianapolis
Kentucky
University of Louisville
RECRUITING
Louisville
Louisiana
Our Lady of the Lake Regional Medical Center
RECRUITING
Baton Rouge
Massachusetts
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Michigan
McLaren Heatlh Care Corporation
RECRUITING
Bay City
Corewell Health Medical Group West
RECRUITING
Grand Rapids
North Carolina
Mission Hospital
RECRUITING
Asheville
Duke University Medical Center
RECRUITING
Durham
Forsyth Medical Center
RECRUITING
Winston-salem
Wake Forest Baptist
RECRUITING
Winston-salem
New Hampshire
Dartmouth Hitchcock Medical Center
RECRUITING
Lebanon
New York
University at Buffalo, Research Foundation
RECRUITING
Buffalo
Oregon
Portland VA Health Care System
RECRUITING
Portland
Pennsylvania
Hospital of the University of Pennsylvania
RECRUITING
Philadelphia
South Carolina
Prisma Health-Upstate
RECRUITING
Greenville
Texas
HCA Healthcare Research Institute/Columbia Medical Center of Plano
RECRUITING
Plano
Utah
Intermountain Health
RECRUITING
Murray
University of Utah
RECRUITING
Salt Lake City
Virginia
Sentara Heart Hospital
RECRUITING
Norfolk
Other Locations
Austria
Medizinische Universitat Wien
RECRUITING
Vienna
Finland
Helsinki University Hospital (HYKS III)
RECRUITING
Helsinki
Wellbeing Services County of Pirkanmaa
RECRUITING
Tampere
Italy
Azienda Ospedaliero Universitaria delle Marche Ospedali Riuniti di Ancona
RECRUITING
Ancona
Azienda Ospedaliero Universitaria Policlinico di Bari
RECRUITING
Bari
Fondazione IRCCS Policlinico San Matteo
RECRUITING
Pavia
AOU Città della Salute e della Scienza di Torino Ospedale S.Giovanni Battista- Molinette
RECRUITING
Torino
Azienda Ospedaliera Universitaria Integrata Verona
RECRUITING
Verona
Netherlands
Amsterdam UMC Research BV
RECRUITING
Amsterdam
Stichting Elisabeth-Tweesteden Ziekenhuis
RECRUITING
Tilburg
VieCuri Medical Center
RECRUITING
Venlo
Spain
Hospital De La Santa Creu i Sant Pau
RECRUITING
Barcelona
Sweden
Karolinska University Hospital
RECRUITING
Stockholm
United Kingdom
University Hospitals of Leicester NHS Trust
RECRUITING
Leicester
Countess of Chester Hospital NHS Foundation Trust
RECRUITING
Liverpool
Imperial College Healthcare NHS Trust, St. Mary's Hospital
RECRUITING
London
St Thomas Hospital - Guys and St. Thomas' NHS
RECRUITING
London
Contact Information
Primary
K Martin
kgmartin@wlgore.com
928-864-2223
Backup
M Drew
mdrew@wlgore.com
928-864-3552
Time Frame
Start Date: 2024-05-07
Estimated Completion Date: 2042-09-30
Participants
Target number of participants: 2000
Treatments
GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC Device)
Patients treated with the EXCC Device
GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE Device)
Patients treated with the IBE Device
Related Therapeutic Areas
Sponsors
Leads: W.L.Gore & Associates